4.8 Article

Impact of Circulating Vitamin D Binding Protein Levels on the Association between 25-Hydroxyvitamin D and Pancreatic Cancer Risk: A Nested Case-Control Study

期刊

CANCER RESEARCH
卷 72, 期 5, 页码 1190-1198

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-11-2950

关键词

-

类别

资金

  1. National Cancer Institute (NCI) at the NIH
  2. U.S. Public Health Service, NCI, NIH [N01-CN-45165, N01-RC-45035, N01-RC-37004, HHSN261201000006C, HHSN261200800001E]

向作者/读者索取更多资源

High concentrations of circulating 25-hydroxyvitamin D [25(OH)D] have been associated with elevated pancreatic cancer risk. As this is contrary to an expected inverse association between vitamin D status and cancer, we examined whether vitamin D binding protein (DBP), the primary carrier of vitamin D compounds in circulation, plays a role in this relationship. Prediagnostic serum DBP and 25(OH)D were studied in relation to risk of pancreatic cancer in a nested case-control study of 234 cases and 234 controls in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish men. ORs and 95% CIs were estimated using logistic regression, and statistical tests were two-sided. We found that DBP and 25(OH)D were correlated (r = 0.27, P < 0.0001), and DBP was inversely associated with pancreatic cancer risk (OR = 0.66, 95% CI = 0.39-1.12, for the highest vs. lowest quartile; P-trend = 0.02). Importantly, this association seemed to have a threshold between quartiles 2 to 4 and quartile 1, and was primarily evident among men with concurrent high 25(OH)D concentrations (OR = 0.33, 95% CI = 0.16-0.70 for highest vs. lowest quartile; P-trend = 0.002), with no association in men with lower serum 25(OH) D (OR 1.28, 95% CI = 0.62-2.61 for highest vs. lowest quartile, P-trend 0.63, P-interaction = 0.01). Men with higher 25(OH) D concentrations and serum DBP below the median showed greatly elevated risk of pancreatic cancer (OR = 5.01, 95% CI 2.33-10.78, for highest vs. lowest quartile; P-trend < 0.0001), while risk was weakly inversely associated with serum 25(OH) D when DBP concentrations were higher (P-interaction = 0.001). Taken together, our findings indicate that higher DBP concentrations may sequester more 25(OH) D and reduce free 25(OH) D bioavailability. Simultaneous examination of DBP and 25(OH) D may be important in determining the association of vitamin D with cancer risk. Cancer Res; 72(5); 1190-8. (C) 2012 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

Eleanor L. Watts, Aurora Perez-Cornago, Georgina K. Fensom, Karl Smith-Byrne, Urwah Noor, Colm D. Andrews, Marc J. Gunter, Michael Holmes, Richard M. Martin, Konstantinos K. Tsilidis, Demetrius Albanes, Aurelio Barricarte, Bas Bueno-de-Mesquita, Chu Chen, Barbara A. Cohn, Niki L. Dimou, Luigi Ferrucci, Leon Flicker, Neal D. Freedman, Graham G. Giles, Edward L. Giovannucci, Gary E. Goodman, Christopher A. Haiman, Graeme J. Hankey, Jiaqi Huang, Wen-Yi Huang, Lauren M. Hurwitz, Rudolf Kaaks, Paul Knekt, Tatsuhiko Kubo, Hilde Langseth, Gail Laughlin, Loic Le Marchand, Tapio Luostarinen, Robert J. MacInnis, Hanna O. Maenpaa, Satu Mannisto, Jeffrey E. Metter, Kazuya Mikami, Lorelei A. Mucci, Anja W. Olsen, Kotaro Ozasa, Domenico Palli, Kathryn L. Penney, Elizabeth A. Platz, Harri Rissanen, Norie Sawada, Jeannette M. Schenk, Par Stattin, Akiko Tamakoshi, Elin Thysell, Chiaojung Jillian Tsai, Shoichiro Tsugane, Lars Vatten, Elisabete Weiderpass, Stephanie J. Weinstein, Lynne R. Wilkens, Bu B. Yeap, Naomi E. Allen, Timothy J. Key, Ruth C. Travis

Summary: This study investigated the associations of free testosterone, total testosterone, and SHBG with prostate cancer. The results demonstrated that free testosterone was associated with prostate cancer, but total testosterone was not. Additionally, the age at blood collection may influence the associations between testosterone and prostate cancer.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Oncology

A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer

Wayne R. Lawrence, Jung-Eun Lim, Jiaqi Huang, Stephanie J. Weinstein, Satu Mannisto, Demetrius Albanes

Summary: The study found no significant relationship between serum alpha-tocopherol concentration and prostate cancer risk. However, higher baseline alpha-tocopherol concentration in men receiving alpha-tocopherol supplementation was associated with reduced risk of prostate cancer. Vitamin E-related genotypes did not modify the association between serum alpha-tocopherol and prostate cancer risk.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Article Oncology

Autoimmune conditions and pancreatic cancer risk in older American adults

Fangcheng Yuan, Ruth M. Pfeiffer, Sachelly Julian-Serrano, Simran Arjani, Michael J. Barrett, Jill Koshiol, Rachael Z. Stolzenberg-Solomon

Summary: There is an association between autoimmune conditions and pancreatic cancer risk, with certain autoimmune conditions being associated with an increased risk of pancreatic cancer.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Public, Environmental & Occupational Health

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Eleanor L. Watts, Aurora Perez-Cornago, Georgina K. Fensom, Karl Smith-Byrne, Urwah Noor, Colm D. Andrews, Marc J. Gunter, Michael Holmes, Richard M. Martin, Konstantinos K. Tsilidis, Demetrius Albanes, Aurelio Barricarte, H. Bas Bueno-de-Mesquita, Barbara A. Cohn, Melanie Deschasaux-Tanguy, Niki L. Dimou, Luigi Ferrucci, Leon Flicker, Neal D. Freedman, Graham G. Giles, Edward L. Giovannucci, Christopher A. Haiman, Graham J. Hankey, Jeffrey M. P. Holly, Jiaqi Huang, Wen-Yi Huang, Lauren M. Hurwitz, Rudolf Kaaks, Tatsuhiko Kubo, Loic Le Marchand, Robert J. MacInnis, Satu Mannisto, E. Jeffrey Metter, Kazuya Mikami, Lorelei A. Mucci, Anja W. Olsen, Kotaro Ozasa, Domenico Palli, Kathryn L. Penney, Elizabeth A. Platz, Michael N. Pollak, Monique J. Roobol, Catherine A. Schaefer, Jeannette M. Schenk, Par Stattin, Akiko Tamakoshi, Elin Thysell, Chiaojung Jillian Tsai, Mathilde Touvier, Stephen K. Van Den Eeden, Elisabete Weiderpass, Stephanie J. Weinstein, Lynne R. Wilkens, Bu B. Yeap, Naomi E. Allen, Timothy J. Key, Ruth C. Travis

Summary: This study found that circulating IGF-I is positively associated with the risk of prostate cancer, particularly aggressive prostate cancer. Higher levels of IGF-II and IGFBP-3 are also associated with increased risk of overall prostate cancer, while higher levels of IGFBP-1 are associated with a decreased risk, but these associations are attenuated after adjusting for IGF-I.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Oncology

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

Hilary A. Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, Nicole Brenner, Mari Nygard, Noemi Bender, Lea Schroeder, Allan Hildesheim, Michael Pawlita, Gypsyamber D'Souza, Kala Visvanathan, Hilde Langseth, Nicolas F. Schlecht, Lesley F. Tinker, Ilir Agalliu, Sylvia Wassertheil-Smoller, Eivind Ness-Jensen, Kristian Hveem, Sara Grioni, Rudolf Kaaks, Maria-Jose Sanchez, Elisabete Weiderpass, Graham G. Giles, Roger L. Milne, Qiuyin Cai, William J. Blot, Wei Zheng, Stephanie J. Weinstein, Demetrius Albanes, Wen-Yi Huang, Neal D. Freedman, Aimee R. Kreimer, Mattias Johansson, Paul Brennan

Summary: Seropositivity for HPV16-E6 oncoprotein is a promising marker for early detection of oropharyngeal cancer (OPC), but the absolute risk of OPC after a positive or negative test is unknown. This study constructed an OPC risk prediction model and found that a substantial proportion of HPV16-E6 seropositive individuals will develop OPC.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Public, Environmental & Occupational Health

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Hilary A. Robbins, Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed, Matthew T. Warkentin, Karl Smith-Byrne, Yonathan Brhane, David Muller, Xiaoshuang Feng, Demetrius Albanes, Melinda C. Aldrich, Alan A. Arslan, Julie Bassett, Christine D. Berg, Qiuyin Cai, Chu Chen, Michael P. A. Davies, Brenda Diergaarde, John K. Field, Neal D. Freedman, Wen-Yi Huang, Mikael Johansson, Michael Jones, Woon-Puay Koh, Stephen Lam, Qing Lan, Arnulf Langhammer, Linda M. Liao, Geoffrey Liu, Reza Malekzadeh, Roger L. Milne, Luis M. Montuenga, Thomas Rohan, Howard D. Sesso, Gianluca Severi, Mahdi Sheikh, Rashmi Sinha, Xiao-Ou Shu, Victoria L. Stevens, Martin C. Tammemaegi, Lesley F. Tinker, Kala Visvanathan, Ying Wang, Renwei Wang, Stephanie J. Weinstein, Emily White, David Wilson, Jian-Min Yuan, Xuehong Zhang, Wei Zheng, Christopher I. Amos, Paul Brennan, Mattias Johansson, Rayjean J. Hung

Summary: The INTEGRAL program aims to develop tools for optimizing LDCT lung cancer screening. It includes the Risk Biomarker and Nodule Malignancy projects, which investigate circulating protein markers for identifying individuals likely to benefit from screening and distinguishing benign versus malignant nodules. A total of 1161 and 1078 proteins were measured, and 21 proteins were selected for performance evaluation in the Risk Biomarker and Nodule Malignancy projects.

ANNALS OF EPIDEMIOLOGY (2023)

Article Biochemistry & Molecular Biology

Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men

Anqi Wang, Yili Xu, Yao Yu, Kevin T. Nead, TaeBeom Kim, Keren Xu, Tokhir Dadaev, Ed Saunders, Xin Sheng, Peggy Wan, Loreall Pooler, Lucy Y. Xia, Stephen Chanock, Sonja Berndt, Susan M. Gapstur, Victoria Stevens, Demetrius Albanes, Stephanie J. Weinstein, Vincent Gnanapragasam, Graham G. Giles, Tu Nguyen-Dumont, Roger L. Milne, Mark M. Pomerantz, Julie A. Schmidt, Konrad H. Stopsack, Lorelei A. Mucci, William J. Catalona, Kurt N. Hetrick, Kimberly F. Doheny, Robert J. MacInnis, Melissa C. Southey, Rosalind A. Eeles, Fredrik Wiklund, Zsofia Kote-Jarai, Adam J. de Smith, David Conti, Chad Huff, Christopher A. Haiman, Burcu F. Darst

Summary: This study found that clonal hematopoiesis of indeterminate potential (CHIP) was not significantly associated with the risk of prostate cancer. Although CHIP was weakly associated with genetic risk of overall prostate cancer, there was no significant association with genes related to aggressive prostate cancer.

HUMAN MOLECULAR GENETICS (2023)

Article Oncology

Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis

Jongeun Rhee, Brenda M. Birmann, Anneclaire J. De Roos, Mara M. Epstein, Otoniel Martinez-Maza, Elizabeth C. Breen, Larry Magpantay, Lynn Levin, Kala Visvanathan, H. Dean Hosgood, Thomas E. Rohan, Sylvia W. Smoller, Bryan A. Bassig, Lihong Qi, Xiao-Ou Shu, Woon-Puay Koh, Wei Zheng, Jian-Min Yuan, Stephanie J. Weinstein, Demetrius Albanes, Qing Lan, Nathaniel Rothman, Mark P. Purdue

Summary: This study found associations between immune activation markers and non-Hodgkin lymphoma, particularly for diffuse large B cell lymphoma (DLBCL). The findings suggest that mechanisms related to immune activation play an important role in the pathogenesis of DLBCL. Further investigation is needed for rarer subtypes such as marginal zone lymphoma (MZL) and T cell lymphoma (TCL).

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk

Simran Arjani, Pedro F. Saint-Maurice, Sachelly Julian-Serrano, Guido Eibl, Rachael Stolzenberg-Solomon

Summary: The study suggests that high body mass index (BMI) during adulthood and associated trajectories are positively associated with pancreatic ductal adenocarcinoma (PDAC), particularly among individuals with early onset adiposity and male sex. Avoidance of excess body weight throughout adulthood may help prevent PDAC.

JNCI CANCER SPECTRUM (2022)

Editorial Material Nutrition & Dietetics

Pancreatic cancer: Are all plant-based diets the same?

Rachael Stolzenberg-Solomon

AMERICAN JOURNAL OF CLINICAL NUTRITION (2023)

Article Public, Environmental & Occupational Health

Lipidomics and pancreatic cancer risk in two prospective studies

Sabine Naudin, Joshua N. Sampson, Steven C. Moore, Demetrius Albanes, Neal D. Freedman, Stephanie J. Weinstein, Rachael Stolzenberg-Solomon

Summary: The study found that abnormal lipid metabolism in prospective studies is associated with pancreatic ductal carcinoma (PDAC). A comprehensive investigation of two prospective studies revealed that 43 lipid species were associated with PDAC.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Nutrition & Dietetics

Dietary Quality and Circulating Lipidomic Profiles in 2 Cohorts of Middle-Aged and Older Male Finnish Smokers and American Populations

Ting Zhang, Sabine Naudin, Hyokyoung G. Hong, Demetrius Albanes, Satu Mannisto, Stephanie J. Weinstein, Steven C. Moore, Rachael Z. Stolzenberg-Solomon

Summary: This study examined the associations between dietary quality indices and serum lipidomic profiles. The results showed that adherence to the Healthy Eating Index (HEI)-2015, Alternate HEI-2010 (AHEI-2010), and alternate Mediterranean Diet Index (aMED) were associated with serum lipid species, particularly triacylglycerols and docosahexaenoic acid (DHA)-containing species, which were related to components of seafood and plant proteins, eicosapentaenoic acid-DHA, fish, or fat ratio.

JOURNAL OF NUTRITION (2023)

Article Environmental Sciences

A metabolomic investigation of serum perfluorooctane sulfonate and perfluorooctanoate

Jongeun Rhee, Erikka Loftfield, Demetrius Albanes, Tracy M. Layne, Rachael Stolzenberg-Solomon, Linda M. Liao, Mary C. Playdon, Sonja I. Berndt, Joshua N. Sampson, Neal D. Freedman, Steven C. Moore, Mark P. Purdue

Summary: This study aimed to investigate the biological effects of PFOS and PFOA on the human body. Through metabolomic analysis, several metabolites associated with PFOS and PFOA were identified, with lipids and xenobiotics being the most common types. These findings provide insights into the potential hazards of PFOS and PFOA.

ENVIRONMENT INTERNATIONAL (2023)

Meeting Abstract Oncology

Autoimmune conditions and pancreatic cancer risk in older American adults.

Fancheng Yuan, Ruth M. Pfeiffer, Sachelly Julian-Serrano, Simran Arjani, Michael J. Barrett, Jill Koshiol, Rachael Z. Stolzenberg-Solomon

CANCER RESEARCH (2022)

Article Oncology

Prediagnostic Serum Vitamin D, Vitamin D Binding Protein Isoform and Cancer Survival

Stephanie J. Weinstein, Alison M. Mondul, Tracy M. Layne, Kai Yu, Jiaqi Huang, Rachael Z. Stolzenberg-Solomon, Regina G. Ziegler, Mark P. Purdue, Wen-Yi Huang, Christian C. Abnet, Neal D. Freedman, Demetrius Albanes

Summary: Higher circulating vitamin D levels were associated with improved overall and lung cancer survival, particularly among individuals with the Gc2 isoform of the vitamin D binding protein.

JNCI CANCER SPECTRUM (2022)

暂无数据